Addus HomeCare (NASDAQ:ADUS – Get Free Report) was upgraded by investment analysts at Citizens Jmp to a “strong-buy” rating in a report issued on Monday,Zacks.com reports.
Several other analysts have also recently issued reports on ADUS. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. KeyCorp assumed coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. Macquarie reissued an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Finally, Oppenheimer increased their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $133.67.
View Our Latest Report on ADUS
Addus HomeCare Stock Performance
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the previous year, the firm posted $1.03 earnings per share. The business’s revenue was up 7.1% compared to the same quarter last year. As a group, analysts forecast that Addus HomeCare will post 4.59 EPS for the current fiscal year.
Insider Activity at Addus HomeCare
In related news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. UMB Bank n.a. lifted its holdings in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the period. Quarry LP bought a new position in shares of Addus HomeCare in the 3rd quarter worth $28,000. Quest Partners LLC purchased a new stake in shares of Addus HomeCare during the 2nd quarter worth $31,000. Innealta Capital LLC purchased a new stake in shares of Addus HomeCare during the 2nd quarter worth $44,000. Finally, Farther Finance Advisors LLC boosted its position in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- About the Markup Calculator
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- How to Calculate Return on Investment (ROI)
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.